Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Israel, O.
Right arrow Articles by Kolodny, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Israel, O.
Right arrow Articles by Kolodny, G. M.

Radiology, Vol 196, 643-646, Copyright © 1995 by Radiological Society of North America

ARTICLES

Bone loss in patients with chronic renal disease: prediction with quantitative bone scintigraphy with SPECT

O Israel, S Gips, R Hardoff, J Rudoy, V Frajewicki, G Iosilevsky, L Bettman, A Frenkel, A Hoffman and GM Kolodny
Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel.

PURPOSE: To determine whether quantitative bone scintigraphy (QBS) with single-energy photon emission computed tomography (SPECT) can help predict which patients with chronic renal disease will show bone mineral density (BMD) loss. MATERIALS AND METHODS: In 18 patients, the percentage of injected dose of technetium-99m methylene diphosphonate per cubic centimeter of bone was measured with QBS SPECT in the lumbar vertebrae and femoral neck. The differences in BMD over an average of 20 months were measured and compared with SPECT measurements. QBS values were also compared with serum bone turnover markers. RESULTS: There was a negative correlation (r = -.54, P < .05 for the lumbar spine and r = -.60, P < .01 for the femoral neck) between QBS values and bone loss. Positive and negative predictive values, sensitivity, and specificity of QBS for bone loss in the lumbar spine were 78%, 71%, 78%, and 71%, respectively, and in the femoral neck, 82%, 100%, 100%, and 78%, respectively. Differences between predictive values of serum bone turnover markers were not statistically significant. CONCLUSION: QBS with SPECT enabled prediction of rapid bone loss in patients with renal disease.


This article has been cited by other articles:


Home page
 ImagingHome page
G J R Cook and I Fogelman
Bone single photon emission computed tomography
Imaging, September 1, 2001; 13(3): 149 - 154.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
O. Israel, Z. Keidar, R. Rubinov, G. Iosilevski, A. Frenkel, A. Kuten, L. Betman, G. M. Kolodny, D. Yarnitsky, and D. Front
Quantitative Bone Single-Photon Emission Computed Tomography for Prediction of Pain Relief in Metastatic Bone Disease Treated With Rhenium-186 Etidronate
J. Clin. Oncol., July 14, 2000; 18(14): 2747 - 2754.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1995 by the Radiological Society of North America.